PCK 2.78% 3.7¢ painchek ltd

FDA De Novo approval date for Painchek's Dementia App, page-3

  1. 584 Posts.
    lightbulb Created with Sketch. 121
    Yes RAP's process was not smooth at all due to differences in clinical trial results etcetc.


    PCK has specified by later/end of 2020 for the FDA approval, and this depends on when the application is submitted. So you should just run with that timeline as they have outlined in the company announcements.


    Here is what a de novo process may look like for a device submitted to FDA which succeeds. 6 Months.
    This is probably the most optimal time, so I would also expect longer just to be conservative.

    LBT : ASX
    21 December 2018, Submitted de novo application for FDA approval

    1.JPG 1.JPG

    20 May 2019, Approval confirmed.

    2.JPG
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.7¢
Change
0.001(2.78%)
Mkt cap ! $60.52M
Open High Low Value Volume
3.4¢ 3.7¢ 3.4¢ $20.62K 594.1K

Buyers (Bids)

No. Vol. Price($)
3 255000 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 243812 1
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.